Explore evidence

25.2 %Among 202 tuberculosis patients in the North Central zone of Nigeria, 51 (25.2%) showed resistance to at least one drug.

Nigeriatuberculosepublished 2019Journal of epidemiology and global healthPubMeddocument of 7 observations

14.8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).

Nigeriatuberculose · VIH/sidapublished 2024BMC public healthPubMeddocument of 4 observations

18.6 %Thirty-eight (18.6%) of the TB patients relocated after 6 months of treatment.

Nigeriatuberculosepublished 2022Frontiers in cellular and infection microbiologyPubMeddocument of 15 observations

10.4 %Probable chronic pulmonary aspergillosis was 10.4% at baseline.

Nigeriapulmonary aspergillosis · tuberculosepublished 2022Frontiers in cellular and infection microbiologyPubMeddocument of 15 observations

25 %The WHO region of Africa accounted for 25% of people with TB globally in 2019.

Nigeriatuberculoseobserved 2019published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 18 observations

36 casesAmong pulmonary TB patients with HIV co-morbidity, 36 (66.7%) were depressed compared to 35 (35.7%) without HIV co-morbidity.

Nigeriatuberculose · VIH/sidaobserved 2017published 2020West African journal of medicinePubMeddocument of 7 observations

60.9 %At baseline, only 60.9% of TB patients scored 'good' or 'very good' quality of life and health on the WHOQOL-Bref.

Nigeriatuberculosepublished 2022Frontiers in cellular and infection microbiologyPubMeddocument of 15 observations

81.2 %The treatment success rate for tuberculosis patients under DOTS was 81.2% overall.

Nigeriatuberculoseobserved 2012-2016published 2022African health sciencesPubMeddocument of 17 observations

82.5 %Majority of the respondents (500, 82.5%) had positive attitude toward tuberculosis.

Nigeriatuberculosepublished 2023African health sciencesPubMeddocument of 7 observations

1.677 AORParticipants who were virally suppressed had a higher likelihood of favorable TB treatment outcome compared to those who were virally unsuppressed (adjusted odds ratio = 1.677, 95% confidence interval = 1.036–2.716).

Nigeriatuberculose · VIH/sidapublished 2024The Pan African medical journalPubMeddocument of 5 observations

97.5 %SD Bioline MPT64 identified 117 MTBC isolates correctly, producing a sensitivity of 97.5% (95% CI, 92.9–99.2).

Nigeriatuberculosepublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 6 observations

4.24 pointsThe least change in HRQoL was on the emotional well-being domain (mean change = 4.24, p=0.05).

Nigeriatuberculosepublished 2018Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 6 observations

441 individuals_per_caseOn average, 441 individuals needed to be screened to diagnose 1 tuberculosis case.

Nigeriatuberculosepublished 2024Global health, science and practicePubMeddocument of 15 observations

72.1 %The diagnostic yield of stool GeneXpert alone was 72.1%.

Nigeriatuberculosepublished 2026BMC infectious diseasesPubMeddocument of 10 observations

6.4 %There were 221 presumptive tuberculosis cases (6.4%) among the screened diabetes mellitus patients.

Nigeriadiabète (non précisé) · tuberculosepublished 2020Advances in respiratory medicinePubMeddocument of 7 observations

75.3 %The annual mean measured successful treatment outcome was 75.3% (±8.8%).

Nigeriatuberculosepublished 2020PloS onePubMeddocument of 10 observations

4.21 AORPeople living with HIV in conflict zones in Nigeria were more than four times more likely to acquire TB than those from non-conflict zones, with an adjusted odds ratio of 4.21.

Nigeriatuberculoseobserved 2018published 2025Tropical medicine & international health : TM & IHPubMeddocument of 7 observations

7.8 %Sixteen (7.8%) of the TB patients were lost to follow-up.

Nigeriatuberculosepublished 2022Frontiers in cellular and infection microbiologyPubMeddocument of 15 observations

55 %55% of the drug-resistant tuberculosis (DR-TB) group were male.

Nigeriatuberculosepublished 2024Journal of global antimicrobial resistancePubMeddocument of 8 observations

4.5 mmol/LA low total serum cholesterol (≤4.5 mmol/L) at baseline was associated with increased risk of tuberculosis in the SECOND-LINE trial.

Nigeriatuberculosepublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

29.7 %Of 425 suspected TB patients in Benue State, Nigeria, 126 (29.7%) yielded mycobacterial isolates.

Nigeriatuberculoseobserved July 2016 to February 2018published 2020Ethiopian journal of health sciencesPubMeddocument of 10 observations

10 %The annual mean measured mortality was 10.0% (±3.6%).

Nigeriatuberculosepublished 2020PloS onePubMeddocument of 10 observations

85 %The national target treatment success rate for tuberculosis control is 85%.

Nigeriatuberculosepublished 2020Journal of infection and public healthPubMeddocument of 16 observations

TB incidence rates are five-to-fifty times higher among inmates in prison settings than the general population.

Nigeriatuberculosepublished 2022PloS onePubMeddocument of 11 observations

5.5 %One (5.5%) of the 18 patients with Mycobacterium tuberculosis (MTB) detection were diagnosed with diabetes mellitus (DM).

Nigeriadiabète (non précisé) · tuberculoseobserved 2017published 2022West African journal of medicinePubMeddocument of 14 observations